Amgen trial to evaluate cardiovascular impact of anemia treatment in CKD patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
DIALYSIS & TRANSPLANTATION | 2004年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [31] Impact of purulent complications and sepsis on cardiovascular system in patients with type 2 diabetes
    E Shalaeva
    B Babadjanov
    U Pulatov
    N Dadabayeva
    A Shalaeva
    Critical Care, 18 (Suppl 2):
  • [32] Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes
    Mody, Reema
    Kalsekar, Iftekhar
    Kavookjian, Jan
    Iyer, Shrividya
    Rajagopalan, Rukmini
    Pawar, Vivek
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (02) : 75 - 83
  • [33] IMPACT OF CARDIOVASCULAR COMORBIDITIES ON PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW
    Vaidya, V.
    Gangan, N.
    Sheehan, J.
    VALUE IN HEALTH, 2014, 17 (03) : A125 - A125
  • [34] Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
    Ostergaard, Jakob A.
    Cooper, Mark E.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2323 - 2324
  • [35] INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL
    Ninomiya, T.
    Perkovic, V.
    de Galan, B. E.
    Zoungas, S.
    Jardine, M.
    Patel, A.
    Cass, A.
    Neal, B.
    Cooper, M.
    MacMahon, S.
    Chalmers, J.
    HYPERTENSION, 2009, 53 (06) : 1115 - 1115
  • [36] Budget Impact Analysis of Empagliflozin in the Treatment of Patients With Type 2 Diabetes With Established Cardiovascular Disease in South Africa
    de Beer, Janetta Catharina
    Snyman, Jacques
    Ker, James
    Miller-Janson, Helen
    Stander, Marthinus
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 33 : 91 - 98
  • [37] BUDGET IMPACT ANALYSIS OF EMPAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AT INCREASED CARDIOVASCULAR RISK IN GREECE
    Gourzoulidis, G.
    Tzanetakos, C.
    Ioannidis, T.
    Tsapas, A.
    Kourlaba, G.
    Papageorgiou, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A476 - A476
  • [38] FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Pochopien, Michal T.
    Cherney, David Z., I
    Folkerts, Kerstin
    Levy, Pierre
    Millier, Aurelie
    Morris, Stephen
    Roy-Chaudhury, Prabir
    Sullivan, Sean D.
    Mernagh, Paul
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (20): : S375 - S382
  • [39] Correction of anemia by dapagliflozin in patients with type 2 diabetes
    Stefansson, Bergur V.
    Heerspink, Hiddo J. L.
    Wheeler, David C.
    Sjostrom, C. David
    Greasley, Peter J.
    Sartipy, Peter
    Cain, Valerie
    Correa-Rotter, Ricardo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
  • [40] Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
    Albai, Oana
    Timar, Bogdan
    Paun, Diana Loreta
    Sima, Alexandra
    Roman, Deiana
    Timar, Romulus
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 3873 - 3878
12345